New program aims to ease burden on caregivers of cancer and diabetes patients

NCT ID NCT07061652

Recruiting now Symptom relief Sponsor: UNC Lineberger Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 4 times

Summary

This study tests a program called enCompass Humana, which provides coaching and resources to unpaid caregivers of adults with both cancer and diabetes. The goal is to see if the program is practical and helpful for caregivers, improving their coping skills and reducing loneliness. About 162 caregivers will take part, receiving up to eight coaching sessions and access to an online tool.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: coaching sessions and resource materials
What this could lead to: If successful, this program could provide a practical way to support caregivers, reducing their stress and improving their ability to cope.
What could go wrong: This is a small, early-stage study focused on feasibility, not a proven treatment. The benefits seen so far may not hold up in larger, more diverse groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer diabetes mellitus neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER DIABETES

Contacts and locations

Locations

Moffitt Cancer Center
RECRUITING

Tampa, Florida, 33612, United States
UNC Lineberger Comprehensive Cancer Center
RECRUITING

Chapel Hill, North Carolina, 27514, United States
University of Vermont Cancer Center
RECRUITING

Burlington, Vermont, 05401, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.